Xiamen Amoytop Biotech Co
web2Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of reco...
Stage
Undisclosed
Funding
Undisclosed
Team
0
0.0Mission ScoreFixed 0-100 scale
About
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
Expert Insight
Xiamen Amoytop Biotech Co profile.
Expert Coverage
No published expert evaluations are available for this project yet.
PharmaceuticalsHealthcare
0team
0evaluations
0subscribers